Cluster-1 was enriched for NPM1-mut AML (50.0%), cluster-2 for cases with altered chromatin/spliceosome genes (37.5%), and cluster-3 for TP53-mut/aneuploid AML (34.4%, p = 0.023, Fig. 5C). Here, TP53 is linked to acute myeloid leukemia.